Displaying items by tag: Programmatic Targets
Monday, 01 August 2011 20:22
Target 8: ≥90% eligible HIV-infected children (0-14 years) receive ART
| Countries and their respective targets |
| Bangladesh None |
| Cambodia Percentage HIV exposed infants who receive a HIV test within 12 months of birth: 70% Percentage HIV exposed infants who start CTX prophylaxis within 2 months of birth: 70% |
| China Percentage HIV exposed infants who receive a HIV test within 18 months of birth: 80% Percentage infants born to HIV-positive women who receive formula feeding: 90% |
| India 80% HIV-positive pregnant women will be reached by PPTCT services (2012) 90% of HIV-exposed infants will receive co-trimoxazole prophylaxis and have access to EID (2012) |
| Indonesia None |
| Lao PDR Percentage of infants born to identified HIV positive mothers receive ARV prophylaxis for PPTCT: 100% |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea Percent of HIV-positive children receiving ART: 80% |
| Thailand Percentage infants born to HIV-positive mothers who receive formula feeding (2011): 100% |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 20:21
Target 7: >90% Eligible HIV-positive pregnant women remain on ART at 12 months post-partum
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia Provision of lifelong ART for pregnant women with HIV who require treatment (2015): 100% |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 20:20
Target 6: ≥90% syphilis sero-positive mothers and exposed infants receive effective treatment
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 20:19
Target 3: ≥90% of pregnant women access antenatal care services and skilled care at birth
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 19:49
Target 5: ≥90% HIV-infected mothers and exposed infants receive effective ARVs to reduce PTCT
| Countries and their respective targets |
| Bangladesh Percentage pregnant women with HIV receive ARV prophylaxis for PPTCT: 80% |
| Cambodia Percentage HIV-positive pregnant women who receive ARVs for PPTCT 75% |
| China Percentage HIV-positive pregnant women who receive ARVs for PPTCT: 90% Percentage of HIV-exposed infants who receive ARV for PPTCT: 90% |
| India None |
| Indonesia None |
| Lao PDR Percentage identified pregnant women with HIV receive ARV prophylaxis for PPTCT: 90% |
| Malaysia None |
| Myanmar Number of HIV-positive pregnant women who received ARVs to reduce the risk of PTCT: 2,680 |
| Nepal By 2011 - Proportion of HIV-positive pregnant women who receive ARVs to reduce the risk of PTCT: 80% |
| Papua New Guinea Percent of HIV positive pregnant women receiving PPTCT services: 80% |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 19:46
Target 2: Zero unmet need for family planning for women living with HIV
| Countries and their respective targets |
| Bangladesh None |
| Cambodia None |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand None |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 19:46
Target 1: 50% Reduction of HIV Incidence among Women aged 15-49 Years
| Countries and their respective targets |
| Bangladesh None |
| Cambodia Percentage male partners who were tested for HIV and received their results: 40% |
| China None |
| India None |
| Indonesia None |
| Lao PDR None |
| Malaysia None |
| Myanmar None |
| Nepal None |
| Papua New Guinea None |
| Thailand Reduction in new HIV infections among couples (2016): 75% Percentage pregnant women whose male partner received HIV testing (2011): 50% |
| Vietnam None |
|
Framework Indicators measured:
|
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 18:23
Programmatic Target 8: >90% HIV-Infected Children (0-14 Years) receive ART
| A key feature of the elimination initiative is its focus on improving the health and survival of women and children in the context of HIV/STIs. This target underscores that PPTCT interventions do not end at delivery, and emphasizes the importance of linking HIV-infected children with lifesaving care and treatment. | |||
| MEASURE OF TARGET | NUMERATOR | DENOMINATOR | METHOD OF MEASUREMENT |
| Percentage of HIV-infected children (aged 0-14 years) who are currently receiving ART (UA Indicator) |
Number of children who are receiving antiretroviral therapy in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period |
Number of women Estimated number of children with advanced HIV infection | Numerator: National programme records drawn from data collected in ART registers at facilities Denominator: Estimated by the method recommended by the UNAIDS/WHO Reference Group on Estimates, Modelling and Projections using Spectrum software |
| ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 8 | |||||
| No. | Indicator | What does it measure | Numerator | Denominator | Method of Measurement |
| 18 | % of infants born to HIV-infected women receiving a virological test for HIV within 2 months of birth (UA Indicator) |
The extent to which infants born to HIV-infected women are tested within the first 2 months of life to determine their HIV status, disaggregated by test results |
Number of infants who received an HIV test within 2 months of birth, during the reporting period, disaggregated by test results Including positive, negative, indeterminate, and rejected for testing by the laboratory. Infants tested should only be counted once. The numerator should only include the most recent test result for an infant tested in the first 2 months of life, and not any earlier tests. | Estimated number of HIV-infected pregnant women giving birth in the last 12 months |
Numerator: Collected from databases held at Early Infant Diagnosis testing laboratories Denominator: Projection model such as Spectrum*
|
| 20 | Percentage of HIV-exposed infants who are receiving exclusive breastfeeding, replacement feeding or mixed feeding at DPT3 visit (Infants will be aged around 3 months) (UA Indicator) |
Feeding of HIV-exposed infants, derived from 24-h recall, measured at the time of the third dose of diphtheria, pertussis and tetanus vaccine (DPT3) | The numerators capture feeding practices only for known HIV-exposed infants who visit a health facility at or around DPT3 visit, and are disaggregated as follows: 10a: Number exclusively breastfeeding 10b: Number receiving replacement feeding 10c: Number receiving mixed feeding |
The number of HIV-exposed infants whose feeding practice has been assessed at DPT3 visit. |
Numerator: National programme records aggregated from stand-alone or integrated HIV-exposed registers Denominator: Total number of exposed infants whose feeding was assessed. |
| 21 | Percentage of infants born to HIV- infected women who are started on co-trimoxazole prophylaxis within 2 months of birth (UA Indicator) |
The provision and coverage of co-trimoxazole prophylaxis for HIV-exposed infants in line with international guidelines | Number of infants born to HIV-infected women started on co-trimoxazole prophylaxis within 2 months of birth in the past 12 months | Estimated number of HIV-infected pregnant women who gave birth in the past 12 months |
Numerator: National programme records aggregated from stand-alone or integrated HIV-exposed registers Denominator: Projection model such as Spectrum* |
* Multiply the number of women who gave birth in the past 12 months by the most recent national estimate of HIV prevalence in in pregnant women (which can be derived from HIV sentinel surveillance in antenatal care clinics), if Spectrum projections are unavailable.
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 18:22
Programmatic Target 7: >90% Eligible HIV-positive pregnant women remain on ART at 12 months post-partum
| A key feature of the elimination initiative is its focus on improving the health and survival of women and children in the context of HIV/STIs. This target underscores that PPTCT interventions do not end at delivery, and emphasize the importance of linking HIV-positive mothers to lifelong treatment and care. | |||
| MEASURE OF TARGET | NUMERATOR | DENOMINATOR | METHOD OF MEASUREMENT |
| Percentage of eligible HIV-positive mothers still alive and known to be on treatment 12 months after ART initiation (among estimated eligible HIV-positive mothers in a given year) | Number of HIV-infected pregnant women attending PPTCT services in the past 12 months assessed as eligible for ART (by either clinical or CD4 criteria) who were started and remain on ART at 12-months post-partum | Estimated number of HIV-positive pregnant women eligible for ART (by either clinical or CD4 criteria) in a given year | Numerator and Denominator: Antenatal care or other register for HIV-positive women, pre-ART or ART register depending on context; reporting form for special cohort analysis |
| ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 7 | |||||
| No. | Indicator | What does it measure | Numerator | Denominator | Method of Measurement |
| 1 | Percentage of HIV-infected pregnant women assessed for ART eligibility through either clinical staging or CD4 testing (UA Indicator) |
Coverage of eligibility assessment for ART among HIV-infected pregnant women, either by clinical staging criteria or by CD4 testing. | Number of HIV-infected pregnant women attending services for PMTCT in the past 12 months assessed for eligibility for antiretroviral therapy by either clinical staging or CD4 testing, on site or by referral (Disaggregate by method of assessment) | Estimated number of HIV-infected pregnant women in the past 12 months | Numerator: National programme data aggregate from health facility registers (ANC, or other register for HIV-positive women, pre-ART, or ART register Denominator: Projection model such as Spectrum* |
| 2 | Percentage of eligible HIV-infected pregnant women started on ART | Coverage of ART among HIV-infected pregnant women who require treatment for their own health. | Number of HIV-infected pregnant women attending services for PMTCT in the past 12 months started on antiretroviral therapy for their own health. | Estimated number of HIV-infected pregnant women eligible for ART in the past 12 months | Numerator and Denominator: National programme data aggregated from health facility (ANC, pre-ART, ART) register or reporting form |
* Multiply the number of women who gave birth in the past 12 months by the most recent national estimate of HIV prevalence in in pregnant women (which can be derived from HIV sentinel surveillance in antenatal care clinics), if Spectrum projections are unavailable.
Published in
Prevention of Parent-to-Child Transmission
Monday, 01 August 2011 18:20
Programmatic Target 6: >90% Syphilis Sero-positive Mothers and Exposed Infants received Effective Treatment
| Dramatic reductions in congenital syphilis infections will not be possible unless syphilis sero-positive pregnant women and their exposed infants receive effective treatment to reduce vertical transmission. | |||
| MEASURE OF TARGET | NUMERATOR | DENOMINATOR | METHOD OF MEASUREMENT |
| Percentage of ANC attendees who were positive for syphilis (UA Indicator) | Number of ANC attendees who tested positive for syphilis | Number of ANC attendees who were tested for syphilis | Numerator and Denominator: National programme data aggregated from health facility data (ANC register, reporting form) |
| Percentage of antenatal care attendees positive for syphilis who received treatment (UA Indicator) |
Number of antenatal care attendees with a positive syphilis serology who received at least one dose of benzathine penicillin 2.4 mU IM | Number of ANC attendees with a positive syphilis serology | Numerator and Denominator: National programme data aggregated from health facility data (ANC or labour and delivery register; reporting form) |
| Percentage of infants born to syphilis seropositive women are treated appropriately | Number of infants born to syphilis sero-positive women who received syphilis treatment to reduce congenital syphilis. | Total number of live births to sero-positive pregnant women | Numerator and Denominator: National Programme data aggregated from health facilty data (labour and delivery, post-partum registers) |
There are no additional indicators for Programmatic Target 6.
Published in
Prevention of Parent-to-Child Transmission